Last reviewed · How we verify
Maitake
At a glance
| Generic name | Maitake |
|---|---|
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Maitake for Integrative Cancer Care (PHASE2)
- The Effects of a Food Product Containing Mushroom Extracts (AndoSanTM) in Subjects with Colorectal Cancer-related Fatigue (NA)
- The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients (NA)
- RiteStart Personal Nutritional Dietary Study (NA)
- Effect of the Nutraceutical "MICODIGEST 2.0" on the Complications After Surgery for Colorectal Cancer (NA)
- Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast Carcinoma (NA)
- Does Maitake Mushroom Extract Enhance Hematopoiesis in Myelodysplastic Patients? (PHASE2)
- Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Maitake CI brief — competitive landscape report
- Maitake updates RSS · CI watch RSS
- Memorial Sloan Kettering Cancer Center portfolio CI